What it means for you
Since April 2024, federal rules let opioid treatment programs give stable patients up to four weeks of methadone to take home, start treatment through telehealth, and admit people without a year-long addiction history.
Who benefits: People treated for opioid addiction at federally certified opioid treatment programs; more than 2,000 programs served over 650,000 patients as of June 2023.
If you get methadone at an opioid treatment clinic, federal rules no longer require months of daily visits before your clinic can consider take-home doses. Your clinic can give you up to 7 days of doses to take home in your first two weeks, up to 14 days starting on day 15, and up to 28 days once you’ve been in treatment for a month. Your care team decides how many you get based on how you’re doing, and state rules can be stricter.
Getting started is easier, too. A clinic can do your first exam by video for methadone, or by video or phone for buprenorphine, if the provider thinks that’s enough to evaluate you. You no longer have to prove a year of opioid addiction to be admitted. Teens don’t have to fail treatment twice first. Clinics can’t refuse your medication because you turn down counseling. You do not file a separate federal application; your clinic decides which options are appropriate under federal and state rules.
During COVID, the Substance Abuse and Mental Health Services Administration let clinics loosen take-home and telehealth rules. The agency, led by Miriam Delphin-Rittmon, made those changes permanent in the biggest update to these rules in more than 20 years. Health and Human Services Secretary Xavier Becerra signed the rule, and it took effect April 2, 2024. In February 2026, HHS under Robert F. Kennedy Jr. made only technical fixes to it. A pending bill, H.R. 5629, would nullify most of the rule, including these take-home, telehealth, and admission changes.
Health care
Where it stands, and how we know
Behind the effort to end it: Erin Houchin (R).
Source for this status, checked November 11, 2026.
Sources
- Medications for the Treatment of Opioid Use Disorder (final rule)Federal Register, February 2, 2024
- Medications for the Treatment of Opioid Use Disorder, 89 FR 7528 (full text)U.S. Government Publishing Office, February 2, 2024
- 42 CFR Part 8 Final Rule: Table of ChangesSubstance Abuse and Mental Health Services Administration, January 31, 2024
- Feds ease restrictions on treating opioid addiction via telehealthPsychiatric Times, April 19, 2024
- Medications for the Treatment of Opioid Use Disorder; CorrectionFederal Register (via U.S. Government Publishing Office), February 23, 2026
- H.R. 5629, 119th CongressCongress.gov, September 30, 2025
How we checked this
Drafted by Claude Opus 5.5 (Anthropic) on November 11, 2026. Checked against its sources by GPT-5.6-sol (OpenAI) on November 11, 2026, which corrected it. Confirmed the rule’s dates, eligibility changes, dose limits, telehealth provisions, credits, and 2026 technical correction. Updated the status for a pending bill that would nullify most of the rule and clarified that take-home doses remain subject to practitioner discretion and state law.
Spot a mistake? Send a correction and we'll fix it.




